KRIBIOLISA™ Epcoritamab ELISA (DUOBODY-CD3xCD20)
ELISA for the detection of Epcoritamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Receive your quote directly from the manufacturer.
Epcoritamab is an investigational drug being developed for the treatment of follicular lymphoma. It is a IgG1-bispecific antibody that binds to CD3 on T cells and CD20 on B cells that directs cytotoxic T cells selectively to tumors to elicit an immune response towards malignant cells.
